title: L-acetyl-carnitine in Huntington's disease: double-blind placebo controlled crossover study of drug effects on movement disorder and dementia.
authors: C G
authors: CG
authors: Goety
authors: C M
authors: CM
authors: Tanner
authors: J A
authors: JA
authors: Cohen
authors: J A
authors: JA
authors: Thelen
authors: V S
authors: VS
authors: Carroll
authors: H L
authors: HL
authors: Klawans
authors: R G
authors: RG
authors: Fariello
mesh_terms: D000108:Acetylcarnitine / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D002331:Carnitine / Q000031:analogs & derivatives*; D003704:Dementia / Q000188:drug therapy* / Q000209:etiology; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006816:Huntington Disease / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000108:Acetylcarnitine; D002331:Carnitine